San Francisco-based startup laboratory Invitae has dramatically expanded its menu of test offerings and is also offering significant discounts to uninsured patients. The company said it was providing … [Read more...]
EMERGING TESTS
Invitae Greatly Expands Testing Panels, Introduces Pricing for Uninsured
April 21, 2016
EMERGING TESTS
FDA Intervenes on Development of New Zika Test
April 5, 2016
The health care sector may have developed a rapid detection diagnostic test for the Zika virus, but the U.S. Food and Drug Administration (FDA) may wind up intervening prior to it making a significant … [Read more...]
EMERGING TESTS
Patient Age Can Impact Gene Expression
April 5, 2016
A new study commissioned by the Provista Diagnostics molecular laboratory has concluded that the age of patients can play a role in the expression of genes. Specifically, the study addressed … [Read more...]
EMERGING TESTS
VolitionRx Uses Nucleosome Technology for Early Cancer Diagnosis
April 5, 2016
Cameron Reynolds CEO, VolitionRx Jake Micallef, Ph.D., CSO, VolitionRx VolitionRx (Belgium) is tackling cancer diagnostics 160 base pairs (BP) at a time. The company’s nucleosome- … [Read more...]
EMERGING TESTS
Methylation Patterns Are New Target for ctDNA Analysis
April 5, 2016
Tests that measure circulating DNA are not entirely new. Yet, until now such tests have been unable to determine the tissue of origin (other than in cases of noninvasive prenatal testing, in which DNA … [Read more...]
EMERGING TESTS
FDA Approves Great Basin Scientific Test for Quick Staph Identification
April 4, 2016
By Ron Shinkman, Editor, Laboratory Industry Report Salt Lake City-based Great Basin Scientific has said it has received clearance from the U.S. Food and Drug Administration for a test that provides … [Read more...]
EMERGING TESTS
Inflammatory Markers May Diagnose Back Conditions
March 15, 2016
Biochemical profiles of blood may improve diagnosis of conditions contributing to low back pain (LBP), according to a study published online Jan. 7 in Arthritis Research & Therapy. LBP is … [Read more...]
EMERGING TESTS
NGS-Based Test for CF Promises Faster, Cheaper, More Thorough Analysis
March 15, 2016
Testing for the cystic fibrosis (CF) helped to fuel the first wave of clinical molecular diagnostics. Now, an assay developed by researchers at the Stanford University taps the power of multiplex … [Read more...]
EMERGING TESTS
Transgenomic Announces Two New Tests for Colorectal Cancer, Melanoma
March 14, 2016
By Ron Shinkman, Editor, Laboratory Industry Report Transgenomic has released two new liquid biopsy tests for colorectal cancer and metastatic melanoma. Both panels will focus on genetic mutations … [Read more...]
TECHNOLOGY
Neoteryx–A Less Ambitious Version of Theranos?
March 8, 2016
A California startup has launched a platform that can gather blood in tiny tubes for assays with all but no inconvenience for patients. And it is not Theranos. Unlike that troubled Silicon Valley … [Read more...]
